Literature DB >> 14598388

CFTR: what's it like inside the pore?

Xuehong Liu1, Stephen S Smith, David C Dawson.   

Abstract

The Cystic Fibrosis Conductance Regulator (CFTR) functions as a cAMP-activated, anion-selective channel, but the structural basis for anion permeation is not well understood. Here we summarize recent studies aimed at understanding how anions move through the CFTR channel, and the nature of the environment anions experience inside the pore. From these studies it is apparent that anion permeability selectivity and anion binding selectivity of the pore are consistent with a model based on a "dielectric tunnel." The selectivity pattern for halides and pseudohalides can be predicted if it is assumed that permeant anions partition between bulk water and a polarizable space that is characterized by an effective dielectric constant of about 19. Covalent labeling of engineered cysteines and pH titration of engineered cysteines and histidines lead to the conclusion that the CFTR anion conduction path includes a positively charged outer vestibule. A residue in transmembrane segment 6 (TM6) (R334) appears to reside in the outer vestibule of the CFTR pore where it creates a positive electrostatic potential that enhances anion conduction. Copyright 2003 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14598388     DOI: 10.1002/jez.a.10311

Source DB:  PubMed          Journal:  J Exp Zool A Comp Exp Biol        ISSN: 1548-8969


  11 in total

1.  Direct and indirect effects of mutations at the outer mouth of the cystic fibrosis transmembrane conductance regulator chloride channel pore.

Authors:  Jing-Jun Zhou; Mohammad Fatehi; Paul Linsdell
Journal:  J Membr Biol       Date:  2007-08-03       Impact factor: 1.843

2.  Tuning of CFTR chloride channel function by location of positive charges within the pore.

Authors:  Yassine El Hiani; Paul Linsdell
Journal:  Biophys J       Date:  2012-10-16       Impact factor: 4.033

3.  Loop diuretics are open-channel blockers of the cystic fibrosis transmembrane conductance regulator with distinct kinetics.

Authors:  Min Ju; Toby S Scott-Ward; Jia Liu; Pissared Khuituan; Hongyu Li; Zhiwei Cai; Stephen M Husbands; David N Sheppard
Journal:  Br J Pharmacol       Date:  2014-01       Impact factor: 8.739

4.  On the origin of asymmetric interactions between permeant anions and the cystic fibrosis transmembrane conductance regulator chloride channel pore.

Authors:  Mohammad Fatehi; Chantal N St Aubin; Paul Linsdell
Journal:  Biophys J       Date:  2006-12-01       Impact factor: 4.033

5.  ATP hydrolysis-dependent asymmetry of the conformation of CFTR channel pore.

Authors:  Oleg V Krasilnikov; Ravshan Z Sabirov; Yasunobu Okada
Journal:  J Physiol Sci       Date:  2011-04-03       Impact factor: 2.781

6.  Cystic fibrosis transmembrane conductance regulator: a molecular model defines the architecture of the anion conduction path and locates a "bottleneck" in the pore.

Authors:  Yohei Norimatsu; Anthony Ivetac; Christopher Alexander; John Kirkham; Nicolette O'Donnell; David C Dawson; Mark S P Sansom
Journal:  Biochemistry       Date:  2012-03-07       Impact factor: 3.162

7.  Location of a permeant anion binding site in the cystic fibrosis transmembrane conductance regulator chloride channel pore.

Authors:  Hussein N Rubaiy; Paul Linsdell
Journal:  J Physiol Sci       Date:  2015-02-12       Impact factor: 2.781

Review 8.  Cystic fibrosis transmembrane conductance regulator (ABCC7) structure.

Authors:  John F Hunt; Chi Wang; Robert C Ford
Journal:  Cold Spring Harb Perspect Med       Date:  2013-02-01       Impact factor: 6.915

9.  The CFTR ion channel: gating, regulation, and anion permeation.

Authors:  Tzyh-Chang Hwang; Kevin L Kirk
Journal:  Cold Spring Harb Perspect Med       Date:  2013-01-01       Impact factor: 6.915

10.  Identification of a lipid scrambling domain in ANO6/TMEM16F.

Authors:  Kuai Yu; Jarred M Whitlock; Kyleen Lee; Eric A Ortlund; Yuan Yuan Cui; H Criss Hartzell
Journal:  Elife       Date:  2015-06-09       Impact factor: 8.140

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.